rdf:type |
|
lifeskim:mentions |
umls-concept:C0019004,
umls-concept:C0021745,
umls-concept:C0030685,
umls-concept:C0030705,
umls-concept:C0037296,
umls-concept:C0041289,
umls-concept:C0205191,
umls-concept:C0391871,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1510438,
umls-concept:C1511790,
umls-concept:C1524112,
umls-concept:C1609538,
umls-concept:C1963578
|
pubmed:issue |
6
|
pubmed:dateCreated |
2009-5-21
|
pubmed:abstractText |
End stage renal disease increases the risk of reactivating latent tuberculosis (LTBI). Interferon-gamma release assays (IGRA) are an alternative to the tuberculin skin test (TST) for detecting LTBI.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1460-2385
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1952-6
|
pubmed:meshHeading |
pubmed-meshheading:19164327-Aged,
pubmed-meshheading:19164327-Aged, 80 and over,
pubmed-meshheading:19164327-Female,
pubmed-meshheading:19164327-Humans,
pubmed-meshheading:19164327-Interferon-gamma,
pubmed-meshheading:19164327-Kidney Failure, Chronic,
pubmed-meshheading:19164327-Male,
pubmed-meshheading:19164327-Middle Aged,
pubmed-meshheading:19164327-Predictive Value of Tests,
pubmed-meshheading:19164327-Renal Dialysis,
pubmed-meshheading:19164327-Tuberculin Test,
pubmed-meshheading:19164327-Tuberculosis, Pulmonary
|
pubmed:year |
2009
|
pubmed:articleTitle |
Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
|
pubmed:affiliation |
Division of Nephrology, Geneva University Hospital, 1211 Geneva 14, Switzerland.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|